Diagnostics
Noninvasive Prenatal Diagnostics
 Noninvasive Prenatal Diagnostics
 Introduction
 Fetal Nucleic Acid Technology
 Information on RhD
 Press Releases
 Contact Us
 Terms & Conditions
 Publications

Press Releases

Access the following announcements for the most up-to-date information about Sequenom.

12/01/08 Next-Generation Noninvasive Technology Shown to Accurately Detect Fetal Down Syndrome in First Trimester of Pregnancy
11/24/08 New Noninvasive Prenatal Diagnostic Technology Allows Diagnosis of Inherited Diseases Such as Cystic Fibrosis Caused by Single Gene Mutations
11/17/08 Sequenom Completes Acquisition of CLIA-Certified Laboratory
10/30/08 Sequenom Announces Exclusive Licensing Agreement with Xenomics for Noninvasive Prenatal Diagnostics Using Transrenal DNA
10/28/08 Sequenom Announces Launch of RNA-Base Noninvasive Aneuploidy (RNA) Study
09/23/08 Sequenom Announces Additional Positive Results for Down Syndrome at Analyst Briefing
09/23/08 Sequenom Annouces Acquisition of CLIA-Certified Laboratory and Partnership with Spectrum Health and Van Andel Research Institute
09/22/08 Sequenom Announces Exclusive Licensing Agreement with Genomic Nanosystems for Digital PCR Technologies and Methods Patents
09/16/08 Sequenom Acquires Exclusive License to Digital PCR and Other Noninvasive Prenatal Diagnotic Intellectual Property
06/04/08 Sequenom Announces Results of Screening for Down Syndrome and Updates Development of Noninvasive Prenatal Diagnostics at Analyst and Investor Briefing
05/07/08 Sequenom Abstract Selected for 'Blue Ribbon' Designation for Presentation at ACOG Annual Meeting
3/17/08 Presentation at ACMG Meeting Supports Utility of Sequenom's SEQureDx Technology in Fetal Gender Determination
02/20/08 Sequenom Announces Key Milestone in Development of Noninvasive Prenatal Down Syndrome Test
01/30/08 Sequenom and NAFNet to Conduct Fetal Rhesus D Study in Collaboration with Baylor College of Medicine
01/23/08 Sequenom to Begin Clinical Assessment of Noninvasive Screening Technology for Down Syndrome
12/27/07 Sequenom Announces New York State Approval of a Noninvasive Prenatal Test
11/05/07 Sequenom to Sponsor Workshop Introducing Prenatal Diagnostics at AMP 2007 Annual Meeting
06/28/07 Lenetix Reports Submission of Clinical Data to New York State Authorities for the Commercial Launch of Non-Invasive Prenatal Rhesus D Incompatibility Test
05/08/07 Sequenom Announces Positive Clinical Data and Performance for the Fetal Rhesus D Genotyping Assay
02/13/07 Sequenom Expands Non-Invasive Prenatal Diagnostic Intellectual Property Portfolio
02/09/07 New Data Supports a Non-Invasive Approach to Routine Prenatal Genetic Testing
02/05/07 Sequenom Names Steven Owings Vice President of Commercial Development, Prenatal Diagnostics
01/29/07 Sequenom and Lenetix Enter Agreement to Develop and Commercialize Rhesus D Prenatal Diagnostic
01/25/07 Sequenom to Present Scientific Poster at the Society of Maternal-Fetal Medicine Annual Meeting
01/08/07 Sequenom and QIAGEN Enter Into Collaboration Targeting Prenatal Diagnostics
11/02/07 Sequenom Benefits From Favorable Ruling in European Patent Office Opposition Proceeding
10/25/06 Sequenom Expands Non-Invasive Prenatal Diagnostic Testing Opportunity
05/17/06 Sequenom Hires Accomplished Diagnostics Executive Elizabeth (Betty) Dragon, Ph.D. to Lead Research and Development
03/27/06 Sequenom Reports Positive Outcomes from Two Siemens-Sponsored Molecular Diagnostic Research Studies of MassARRAY(R) Platform
10/23/05 Sequenom Secures Rights to Key Non-Invasive Prenatal Diagnostic Intellectual Property